Internal Medicine, Hematology & Oncology · Huntersville, NC
NPI
1811949308
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
9930 Kincey Ave Ste 165
Huntersville, NC, 28078
Phone (704) 947-5005
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
74,382 services
Medicare patients, 2024
481
Average age 75
Drug cost, 2024
$11.2M
2,074 prescriptions
Company payments, 2025
$2,772
From 50 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William R Mitchell was code J1439 (injection, ferric carboxymaltose, 1 mg), 10,501 times for 12 patients. In total William R Mitchell billed 74,382 services in 163 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 10,501 | 12 | $0.87 | $9,162 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 6,150 | 51 | $0.10 | $618 |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 3,273 | 15 | $35.03 | $115K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,820 | 91 | $0.09 | $252 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2,180 | 11 | $5.76 | $13K |
| J0897 Injection, denosumab, 1 mg | Office | 2,105 | 29 | $20.60 | $43K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,902 | 21 | $15.05 | $29K |
| 85025 Blood Count | Office | 1,043 | 349 | $7.58 | $7,910 |
| 80053 Clinical Chemistry | Office | 1,009 | 345 | $10.33 | $10K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 882 | 13 | $36.11 | $32K |
| 36415 Venipuncture Blood Collection | Office | 803 | 337 | $7.63 | $6,127 |
| 96367 Intravenous Infusion, Hydration | Office | 796 | 98 | $21.64 | $17K |
| 99214 Office E&M - Established | Office | 671 | 274 | $92.83 | $62K |
| 82784 Immunoassay | Office | 661 | 93 | $9.11 | $6,024 |
| 83615 Clinical Chemistry | Office | 556 | 206 | $5.90 | $3,280 |
By year: 2022 $1.6M for 80,924 services; 2023 $1.6M for 76,997 services; 2024 $1.3M for 74,382 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,043 | 349 | $7.58 | $7,910 |
| 80053 Clinical Chemistry | 1,009 | 345 | $10.33 | $10K |
| 36415 Venipuncture Blood Collection | 803 | 337 | $7.63 | $6,127 |
| 82784 Immunoassay | 661 | 93 | $9.11 | $6,024 |
| 83615 Clinical Chemistry | 556 | 206 | $5.90 | $3,280 |
| 82728 Clinical Chemistry | 531 | 204 | $13.31 | $7,069 |
| 83550 Clinical Chemistry | 454 | 189 | $8.53 | $3,874 |
| 83540 Clinical Chemistry | 419 | 177 | $6.33 | $2,651 |
| 82607 Clinical Chemistry | 173 | 123 | $14.70 | $2,543 |
| 82378 Clinical Chemistry | 156 | 81 | $18.58 | $2,898 |
Medicare prescription drug claims, 2024
In 2024, the drug William R Mitchell prescribed most often to Medicare patients was Procrit (Epoetin Alfa), with 259 prescriptions and refills. In total William R Mitchell wrote 2,074 Medicare prescriptions that cost $11.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Procrit Epoetin Alfa | 259 | 261 | 33 | $482K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 251 | 255 | 28 | $2.3M |
| Eliquis Apixaban | 66 | 76 | Under 11 | $46K |
| Xarelto Rivaroxaban | 54 | 85 | 11 | $45K |
| Letrozole Generic | 49 | 112 | 14 | $900 |
| Xtandi Enzalutamide | 49 | 57 | Under 11 | $560K |
| Ojjaara Momelotinib Dihydrochloride | 45 | 45 | Under 11 | $1.2M |
| Prolia Denosumab | 43 | 258 | 35 | $74K |
| Levothyroxine Sodium Generic | 41 | 74 | Under 11 | $280 |
| Ibrance Palbociclib | 38 | 38 | Under 11 | $608K |
| Zoledronic Acid Zoledronic Acid/Mannitol-Water | 38 | 423 | 38 | $6,344 |
| Prednisone Generic | 36 | 38 | 25 | $99.24 |
| Sandostatin Lar Depot Octreotide Acetate,mi-Spheres | 35 | 35 | Under 11 | $182K |
| Darzalex Daratumumab | 34 | 34 | Under 11 | $268K |
| Panzyga Immun Glob G(Igg)-Ifas/Glycine | 33 | 33 | Under 11 | $205K |
Brand drugs: 1,452 claims; generic drugs: 622 claims; opioid claims: 42.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William R Mitchell $2,772 ($2,772 in general payments such as food, travel and fees) from 50 companies. The largest payer was Novartis Pharmaceuticals Corporation with $195.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 7 | $195 |
| GlaxoSmithKline, LLC. GSK | 8 | $175 |
| PharmaEssentia USA Corporation 6446.TW | 3 | $137 |
| Incyte Corporation INCY | 5 | $135 |
| Abbvie Inc. ABBV | 6 | $127 |
| Array Biopharma Inc PFE | 6 | $118 |
| Pfizer Inc. PFE | 5 | $110 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $98.98 |
| Daiichi Sankyo Inc. 4568.T | 4 | $96.08 |
| Janssen Biotech, Inc. JNJ | 3 | $95.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.